Figure 2 | Scientific Reports

Figure 2

From: Impact of anemia requiring transfusion or erythropoiesis-stimulating agents on new-onset cardiovascular events and mortality after continuous renal replacement therapy

Figure 2

Subgroup analysis stratified according to age, sex, and comorbidities for cardiovascular events and all-cause mortality. (A) Cardiovascular events and (B) all-cause mortality. A cardiovascular event was defined as a composite outcome of heart failure, acute myocardial infarction, revascularization, or stroke.

Back to article page